This protocol is judged by an institutional assessment board, an unbiased team that assessments any clinical trials involving people. If a examine will involve a Schedule I drug, as soon as the board approves the protocol as ethical, the scientists have to make an application for an investigational new drug (IND) amount from the FDA.Weiser urged s